What Your Proteins Reveal About Your Health

What Proteins Reveal About Metabolic Health
What Proteins Reveal About Stress and Inflammation
What Proteins Reveal About Hormonal Signaling
What Proteins Reveal About Tissue Health and Adaptation
What Proteins Reveal About Aging
Proteins as a Lens Into Health
References and Further Reading

Most of what we measure in health is relatively static. It tells us what’s there, or what might happen, but not always what the body is actually doing at a given moment. That’s where the proteome becomes useful. As the full set of proteins expressed at any given time, it reflects the activity of biological systems as they respond to changes in physiology, lifestyle, and environment.

Because proteins are directly involved in processes like metabolism, immune defence, hormonal signaling, and tissue maintenance, shifts in the proteome offer a more immediate view of how these systems are functioning. In that sense, it provides a way to move beyond isolated markers and towards a more integrated understanding of physiology.

This article examines how proteomic profiling is being used across key physiological processes, and how tracking these changes over time can support more personalised approaches to health assessment and intervention. 

What Proteins Reveal About Metabolic Health

One of the clearest places this shows up is in metabolic health. Keeping metabolism stable relies on coordinated changes in proteins involved in glucose handling, insulin signaling, and lipid transport, systems that are constantly adjusting to what we eat, how we move, and how much energy we need. 

Plasma proteomics can pick up early shifts in these pathways, often before traditional clinical markers start to move. Studies that follow people over time have shown that changes in proteins like insulin receptor substrates (IRS1, IRS2), apolipoproteins (ApoA1, ApoB), and related regulators can point to early insulin resistance, dyslipidaemia, and disrupted energy metabolism.^1,2

Importantly, it’s not just the usual metabolic markers that change. Broader protein panels like signaling, inflammatory, and extracellular matrix (ECM)–related proteins can give a more complete picture of metabolic function. In some cases, they also improve the ability to predict future risk compared to measures like fasting glucose or HbA1c.

This evidence underscores the proteome’s adaptability, where coordinated shifts in protein levels reflect dynamic responses to metabolic demand. Such changes capture early systemic alterations, providing insight into metabolic function and potential avenues for early intervention before overt disease manifests.

What Proteins Reveal About Stress and Inflammation

Proteins also offer a direct window into how the body responds to stress and regulates inflammation. These systems are largely protein-driven, with cytokines, complement factors, and acute-phase proteins working together in networks that respond to infection, exercise, and environmental exposures.³

One of the advantages of proteomic profiling is that it can separate short-term changes from more persistent ones. Chronic low-grade inflammation, for example, shows up as small but sustained increases in proteins like C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), and is associated with cardiometabolic multimorbidity.⁴

Lifestyle and environmental factors further modulate these responses. Sleep restriction increases pro-inflammatory proteins, while exposure to air pollutants similarly elevates CRP and cytokine levels.^5,6

Lifestyle plays a clear role here. Sleep restriction tends to increase pro-inflammatory proteins, while exposure to air pollution has similar effects.^5,6 On the other hand, regular exercise and a balanced diet are associated with lower levels of CRP and IL-6, reflecting better inflammatory control.⁷

Exercise is a good example of how flexible the proteome is. Training doesn’t just trigger a few changes; it reshapes hundreds of circulating proteins involved in processes like tissue remodeling, blood vessel formation, and metabolism.⁸

These changes reflect recovery, physiological plasticity, and the body’s capacity to maintain equilibrium, underscoring the value of proteomic monitoring for personalized health.

What Proteins Reveal About Hormonal Signaling

Another important layer comes from hormonal signaling. Hormones don’t act in isolation. Instead, they rely on networks of proteins to be produced, transported, and to exert their effects. 

Proteomic approaches, particularly mass spectrometry (MS), allow for detailed measurement of circulating peptide hormones, hormone-binding proteins, and their downstream effectors. This gives a more complete picture of how endocrine systems are functioning.

These methods also provide insight into how hormones are processed and modified. Proteomic and peptidomic analyses can characterize precursor-derived peptides and identify post-translational modifications (PTMs) that influence protein activity, adding another layer of functional detail.⁹

For instance, proteomic profiling enables the detection of alterations in proteins linked to thyroid function, growth factor signaling, reproductive hormones, and adrenal activity. Integrated plasma proteomics studies also demonstrate how circulating hormone levels are reflected in the proteome, influencing metabolic and systemic regulation.¹⁰

In practice, this means detecting changes across systems like thyroid function, growth factor signaling, reproductive hormones, and adrenal activity.¹⁰ More detailed analyses show how entire signaling pathways shift - for example, in studies looking at differences in sensitivity to glucocorticoids, where distinct protein patterns are linked to how individuals respond to cortisol.^11,13

Rather than focusing on single hormone levels, proteomics shows how these systems are working as a whole.

What Proteins Reveal About Tissue Health and Adaptation

All of these signals eventually show up at the level of tissue, where the body is constantly maintaining and rebuilding itself. Tissue health depends on coordinated activity between structural proteins, extracellular matrix (ECM) components, growth factors, and enzymes involved in repair and remodeling.^14,15

Circulating proteins can reflect this ongoing process. For example, fragments of the ECM and regulators of matrix metalloproteinases (MMPs) give insight into how tissues like muscle, blood vessels, and the heart are being remodeled.^14,15

Proteomic profiling captures this dynamic process. In skeletal muscle, protein changes reflect responses to both activity and inactivity, including shifts in mitochondrial function, protein turnover, and contraction pathways.¹⁶ These patterns offer a window into how tissue responds to training, disuse, and ageing. 

Similar signals are evident in the cardiovascular system. Increases in cardiac-specific proteins or markers of endothelial dysfunction can indicate early vascular changes and subclinical stress, often before clinical symptoms appear.¹⁷

These findings illustrate how proteomics integrates molecular, tissue, and systemic signals to provide a unified perspective on integrated physiological performance.

What Proteins Reveal About Aging

Over time, these patterns build up and start to reflect the ageing process. Rather than being a single, uniform trajectory, ageing shows up as coordinated shifts across the proteome, often involving inflammation, tissue remodeling, metabolism, and cellular senescence.¹⁸

Large studies have identified protein signatures that track both chronological age and what’s often referred to as biological age. These have led to the development of “proteomic clocks,” which are associated with frailty, disease risk, and mortality - sometimes more strongly than traditional markers.¹⁹

What’s interesting is how much variation there is. Two people of the same chronological age can have very different proteomic profiles, and even within one person, different organ systems can appear to age at different rates. These differences are linked to health outcomes, independent of genetics and age alone.^19,20

With newer technologies, it’s now possible to track thousands of proteins over time, giving a clearer picture of how these patterns evolve.²¹ Combined with other data, this helps build a more detailed understanding of ageing as a system-level process.

Proteins as a Lens Into Health

The proteome offers a way of looking at biology as it is functioning, rather than as it is inferred. Because proteins are directly involved in cellular processes, they provide a more immediate sense of how physiological systems are operating at any given time.

As measurement approaches have improved, this has become easier to work with in practice. High-throughput platforms and longitudinal datasets now allow for repeated assessment across large numbers of proteins, making it possible to observe how these systems change rather than relying on single time points.

There are still limitations, particularly around standardisation, data integration, and interpretation. But even with these constraints, the shift is noticeable. Looking at proteins in this way moves the focus away from isolated values and towards patterns:how systems respond, stabilise, and adapt over time.

References and Further Reading

1. Gudmundsdottir, V., Zaghlool, S. B., Emilsson, V., Aspelund, T., Ilkov, M., Gudmundsson, E. F., Jonsson, S. M., Zilhão, N. R., Lamb, J. R., Suhre, K., Jennings, L. L., & Gudnason, V. (2020). Circulating Protein Signatures and Causal Candidates for Type 2 Diabetes. Diabetes, 69(8), 1843–1853. DOI:10.2337/db19-1070, https://pmc.ncbi.nlm.nih.gov/articles/PMC7372075/
2. Elhadad, M. A., Jonasson, C., Huth, C., Wilson, R., Gieger, C., Matias, P., Grallert, H., Graumann, J., Gailus-Durner, V., Rathmann, W., von Toerne, C., Hauck, S. M., Koenig, W., Sinner, M. F., Oprea, T. I., Suhre, K., Thorand, B., Hveem, K., Peters, A., & Waldenberger, M. (2020). Deciphering the Plasma Proteome of Type 2 Diabetes. Diabetes, 69(12), 2766–2778. DOI:10.2337/db20-0296, https://pmc.ncbi.nlm.nih.gov/articles/PMC7679779/
3. McKetney, J., Jenkins, C. C. M., Minogue, C., Mach, P. M., Hussey, E. K., Glaros, T. G., Coon, J., & Dhummakupt, E. S. (2022). Proteomic and metabolomic profiling of acute and chronic stress events associated with military exercises. Molecular Omics, 18, 279–295. DOI:10.1039/D1MO00271F, https://pubs.rsc.org/en/content/articlehtml/2022/mo/d1mo00271f⁠
4. Cheng, W., Du, Z., & Lu, B. (2024). Chronic low‑grade inflammation associated with higher risk and earlier onset of cardiometabolic multimorbidity in middle‑aged and older adults: A population‑based cohort study. Scientific Reports, 14, 22635. DOI:10.1038/s41598‑024‑72988‑7, https://pmc.ncbi.nlm.nih.gov/articles/PMC11442589/
5. Zhang, Y., Zhao, W., Liu, K., Chen, Z., Fei, Q., Ahmad, N., & Yi, M. (2023). The causal associations of altered inflammatory proteins with sleep duration, insomnia and daytime sleepiness. Sleep, 46(10), zsad207. DOI:10.1093/sleep/zsad207, https://academic.oup.com/sleep/article/46/10/zsad207/7236585
6. Xu, Z., Wang, W., Liu, Q., Li, Z., L, L., Ren, L., Deng, F., Guo, X., & Wu, S. (2022). Association between gaseous air pollutants and biomarkers of systemic inflammation: A systematic review and meta‑analysis. Environmental Pollution, 292, 118336. DOI:10.1016/j.envpol.2021.118336, https://www.sciencedirect.com/science/article/abs/pii/S0269749121019187
7. Magni, O., Arnaoutis, G., & Panagiotakos, D. (2025). The impact of exercise on chronic systemic inflammation: A systematic review and meta‑meta‑analysis. Sport Sciences for Health, 21, 1405–1417. DOI:10.1007/s11332-025-01445-3, https://link.springer.com/article/10.1007/s11332-025-01445-3
8. Robbins, J. M., Rao, P., Deng, S., Keyes, M. J., Tahir, U. A., Katz, D. H., Jean Beltran, P. M., Marchildon, F., Barber, J. L., Peterson, B., Gao, Y., Correa, A., Wilson, J. G., Smith, J. G., Cohen, P., Ross, R., Bouchard, C., Sarzynski, M. A., & Gerszten, R. E. (2023). Plasma proteomic changes in response to exercise training are associated with cardiorespiratory fitness adaptations. JCI Insight, 8(7), e165867. DOI:10.1172/jci.insight.165867, https://pubmed.ncbi.nlm.nih.gov/37036009/
9. Coassolo, L., Wiggenhorn, A., & Svensson, K. J. (2025). Understanding peptide hormones: from precursor proteins to bioactive molecules. Trends in Biochemical Sciences, 50(6), 481-494, DOI:10.1016/j.tibs.2025.03.014, https://www.cell.com/trends/biochemical-sciences/fulltext/S0968-0004(25)00063-5
10. Masood, A., Benabdelkamel, H., Ekhzaimy, A. A., & Alfadda, A. A. (2020). Plasma‑Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment. Molecules, 25(12), 2831. DOI:10.3390/molecules25122831, https://www.mdpi.com/1420-3049/25/12/2831
11. Monteiro‑Martins, S., Sterenborg, R. B. T. M., Borisov, O., Scherer, N., Cheng, Y., Medici, M., Köttgen, A., & Teumer, A. (2024). New insights into the hypothalamic‑pituitary‑thyroid axis: A transcriptome‑ and proteome‑wide association study. European Thyroid Journal, 13(3), e240067. DOI:10.1530/ETJ‑24‑0067, https://pubmed.ncbi.nlm.nih.gov/38805593/
12. Zhang, Y., Chen, P., & Fang, X. (2024). Proteomic and metabolomic analysis of GH deficiency‑induced NAFLD in hypopituitarism: Insights into oxidative stress. Frontiers in Endocrinology, 15, 1371444. DOI:10.3389/fendo.2024.1371444, https://pubmed.ncbi.nlm.nih.gov/38836220/
13. Nicolaides, N. C., Makridakis, M., Stroggilos, R., Lygirou, V., Koniari, E., Papageorgiou, I., Sertedaki, A., Zoidakis, J., & Charmandari, E. (2022). Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies A Novel Proteomic Signature. Biomedicines, 10(1), 184. DOI:10.3390/biomedicines10010184, https://pmc.ncbi.nlm.nih.gov/articles/PMC8773719/
14. Pattamaprapanont, P., Cooney, E. M., MacDonald, T. L., Paulo, J. A., Pan, H., Dreyfuss, J. M., & Lessard, S. J. (2024). Matrisome proteomics reveals novel mediators of muscle remodeling with aerobic exercise training. Matrix Biology Plus, 23, 100159. DOI:10.1016/j.mbplus.2024.100159, https://www.sciencedirect.com/science/article/pii/S259002852400019X
15. Huber, M. P., Brody, J. A., Sitlani, C. M., Austin, T. R., Tahir, U. A., Deng, S., Meena, D., Chen, J., Matsushita, K., Ballantyne, C. M., Coresh, J., Gerszten, R. E., Tracy, R. P., Ye, T., Psaty, B. M., Bis, J. C., Floyd, J. S. (2026). Plasma proteomics and incident coronary heart disease. Communications Medicine, 6, 98. DOI:10.1038/s43856-025-01363-y, https://www.nature.com/articles/s43856-025-01363-y
16. Deane, C. S., Phillips, B. E., Willis, C. R. G., Wilkinson, D. J., Smith, K., Higashitani, N., Williams, J. P., Szewczyk, N. J., Atherton, P. J., Higashitani, A., & Etheridge, T. (2023). Proteomic features of skeletal muscle adaptation to resistance exercise training as a function of age. Geroscience, 45(3), 1271–1287. DOI:10.1007/s11357-022-00658-5, https://pubmed.ncbi.nlm.nih.gov/36161583/
17. Iglesias, M. J., Kruse, L. D., Sanchez‑Rivera, L., Enge, L., Dusart, P., Hong, M.-G., Uhlén, M., Renné, T., Schwenk, J. M., Bergström, G., Odeberg, J., & Butler, L. M. (2021). Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(12), 2990–3004. DOI:10.1161/ATVBAHA.121.316779, https://pubmed.ncbi.nlm.nih.gov/34706560/
18. Argentieri, M. A., Xiao, S., Bennett, D., Winchester, L., Nevado‑Holgado, A. J., Ghose, U., Albukhari, A., Yao, P., Mazidi, M., Lv, J., Millwood, I. Y., Fry, H., Rodosthenous, R. S., Partanen, J., Zheng, Z., Kurki, M., Daly, M. J., Palotie, A., Adams, C. J., Li, L., ... van Duijn, C. M. (2024). Proteomic aging clock predicts mortality and risk of common age‑related diseases in diverse populations. Nature Medicine, 30, 2450–2460. DOI:10.1038/s41591‑024‑03164‑7, https://www.nature.com/articles/s41591-024-03164-7
19. Wang, Y., Xiao, S., Liu, B., Jiang, R., Liu, Y., Hang, Y., Chen, L., Chen, R., Vitiello, M. V., Bennett, D., Wang, B., Lv, J., Yu, C., Haslam, D. E., Zheng, Q., Gerszten, R. E., Bao, Y., Shi, J., Xie, J., … Chan, A. T. (2026). Organ‑specific proteomic aging clocks predict disease and longevity across diverse populations. Nature Aging, 6, 162-180, DOI:10.1038/s43587‑025‑01016‑8, https://www.nature.com/articles/s43587-025-01016-8
20. Argentieri, M. A., Amin, N., Nevado‑Holgado, A. J., Sproviero, W., Collister, J. A., Keestra, S. M., Kuilman, M. M., Ginos, B. N. R., Ghanbari, M., Doherty, A., Hunter, D. J., Alvergne, A., & van Duijn, C. M. (2025). Integrating the environmental and genetic architectures of aging and mortality. Nature Medicine, 31(3), 1016–1025. DOI:10.1038/s41591‑024‑03483‑9, https://www.nature.com/articles/s41591-024-03483-9
21. Tang, J., Yue, L., Xu, Y., Xu, F., Cai, X., Fu, Y., Miao, Z., Gou, W., Hu, W., Xue, Z., Deng, K., Shen, L., Jiang, Z., Shuai, M., Liang, X., Xiao, C, Xie, Y., Guo, T., Yu-Ming, C., & Zheng, J-. S. (2025). Longitudinal serum proteome mapping reveals biomarkers for healthy ageing and related cardiometabolic diseases. Nature Metabolism, 7(1), 166–181. https://doi.org/10.1038/s42255-024-01185-7, https://www.nature.com/articles/s42255-024-01185-7

Last Updated: Mar 23, 2026